Differential sensitivity to paclitaxel-induced apoptosis and growth suppression in paclitaxel-resistant cell lines established from HEC-1 human endometrial adenocarcinoma cells

International Journal of Oncology

Volumn 41, Issue 5, 2012, Pages 1837-1844

  Tanaka, Tetsuji ^a   Toujima, Saori ^b   Tanaka, Junko ^c  

^a Santamaria Hospital   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c KOBE UNIVERSITY   (Japan)

Author keywords

Apoptosis; Drug resistance; Endometrial adenocarcinoma; Paclitaxel

Indexed keywords

4 HYDROXYCYCLOPHOSPHAMIDE; CISPLATIN; ETOPOSIDE; FLUOROURACIL; MITOMYCIN C; PACLITAXEL; PIRARUBICIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CHROMOSOME 18; CHROMOSOME 4; DNA FRAGMENTATION; DRUG MECHANISM; DRUG SENSITIVITY; ENDOMETRIUM CARCINOMA; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; KARYOTYPING; MOLECULE; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTIGENS, SURFACE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; DRUG RESISTANCE, NEOPLASM; ENDOMETRIAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KARYOTYPE; PACLITAXEL;

EID: 84867792638     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1600     Document Type: Article

References (28)

1. Chen YX, Wang Y, Fu CC, Diao F, Song LN, Li ZB, Yang R and Lu J: Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells. Endocr Relat Cancer 17: 39-50, 2010.
2. Dong Y, Tan OL, Loessner D, Stephens C, Walpole C, Boyle GM, Parsons PG and Clements JA: Kallikrein-related peptidase 7 promotes multicellular aggregation via the alpha(5) beta(1) integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma. Cancer Res 70: 2624-2633, 2010.
3. Loessner D, Stok KS, Lutolf MP, Hutmacher DW, Clements JA and Rizzi SC: Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials 31: 8494-8506, 2010.
4. Stumm S, Meyer A, Lindner M, Bastert G, Wallwiener D and Gückel B: Paclitaxel treatment of breast cancer cell lines modulates Fas/Fas ligand expression and induces apoptosis which can be inhibited through the CD40 receptor. Oncology 66: 101-111, 2004. (Pubitemid 38608376)
5. Huang Y, Ibrado AM, Reed JC, Bullock G, Ray S, Tang C and Bhalla K: Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells. Leukemia 11: 253-257, 1997. (Pubitemid 27085170)
6. Kamazawa S, Kigawa J, Kanamori Y, Itamochi H, Sato S, Iba T and Terakawa N: Multidrug resistance gene-1 is a useful predictor of Paclitaxel-based chemotherapy for patients with ovarian cancer. Gynecol Oncol 86: 171-176, 2002. (Pubitemid 34953500)
7. Swanton C, Nicke B, Schuett M, Eklund AC, Ng C, Li Q, Hardcastle T, Lee A, Roy R, East P, Kschischo M, Endesfelder D, Wylie P, Kim SN, Chen JG, Howell M, Ried T, Habermann JK, Auer G, Brenton JD, Szallasi Z and Downward J: Chromosomal instability determines taxane response. Proc Natl Acad Sci USA 106: 8671-8676, 2009.
8. Satyaswaroop PG, Frost A and Gurpide E: Metabolism and effects of progesterone in the human endometrial adenocarcinoma cell line HEC-1. Steroids 35: 21-37, 1980. (Pubitemid 11252899)
9. Gibas Z, Prout GR, Conolly JG, Pontes JE and Sandberg AA: Nonrandom chromosome changes in transitional cell carcinoma of the bladder. Cancer Res 44: 1257-1264, 1984. (Pubitemid 14151537)
10. Yoshida MA, Ohyashiki K, Ochi H, Gibas Z, Pontes JE, Prout GR Jr, Huben R and Sandberg AA: Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma. Cancer Res 46: 2139-2147, 1986. (Pubitemid 16117922)
11. Yunis JJ: New chromosome techniques in the study of human neoplasia. Hum Pathol 12: 540-549, 1981.
12. Tanaka T, Bai T, Yukawa K, Utsunomiya T and Umesaki N: Reduced radiosensitivity and increased CD40 expression in cyclophosphamide-resistant subclones established from human cervical squamous cell carcinoma cells. Oncol Rep 14: 941-948, 2005.
13. Tanaka T, Bai T and Toujima S: Establishment and characterization of monoclonal 5-fluorouracil-resistant cell lines derived from human endometrial adenocarcinoma. Int J Oncol 37: 731-736, 2010.
14. Tanaka T, Toujima S and Umesaki N: Growth-inhibitory signals by activin A do not affect anticancer drug-sensitivity and acquired multi-drig-resistance in human ovarian endometrioid adenocarcinoma OVK-18 cells. Oncol Rep 11: 667-671, 2004.
15. Tanaka T, Bai T, Yukawa K and Umesaki N: Optimal combination chemotherapy and chemoradiotherapy with etoposide for advanced cervical squamous cancer cells in vitro. Oncol Rep 15: 939-947, 2006.
16. Ohbayashi M, Yasuda M, Kawakami I, Kohyama N, Kobayashi Y and Yamamoto T: Effect of interleukins response to ECM-induced acquisition of drug resistance in MCF-7 cells. Exp Oncol 30: 276-282, 2008.
17. To K, Fotovati A, Reipas KM, Law JH, Hu K, Wang J, Astanehe A, Davies AH, Lee L, Stratford AL, Raouf A, Johnson P, Berquin IM, Royer HD, Eaves CJ and Dunn SE: Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance. Cancer Res 70: 2840-2851, 2010.
18. Işeri OD, Kars MD, Arpaci F and Gündüz U: Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins. Cancer Chemother Pharmacol 65: 447-55, 2010.
19. Lanni JS, Lowe SW, Licitra EJ, Liu JO and Jacks T: p53-independent apoptosis induced by paclitaxel through an indirect mechanism. Proc Natl Acad Sci USA 94: 9679-83, 1997. (Pubitemid 27408122)
20. Biswas RS, Cha HJ, Hardwick JM and Srivastava RK: Inhibition of drug-induced Fas ligand transcription and apoptosis by Bcl-XL. Mol Cell Biochem 225: 7-20, 2001. (Pubitemid 33014628)
21. Shivanna M and Srinivas SP: Microtubule stabilization opposes the (TNF-alpha)-induced loss in the barrier integrity of corneal endothelium. Exp Eye Res 89: 950-959, 2009.
22. Voorzanger-Rousselot N, Alberti L and Blay JY: CD40L induces multidrug resistance to apoptosis in breast carcinoma and lymphoma cells through caspase independent and dependent pathways. BMC Cancer 18: 75, 2006.
23. Wang MY, Chen PS, Prakash E, Hsu HC, Huang HY, Lin MT, Chang KJ and Kuo ML: Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1. Cancer Res 69: 3482-3491, 2009.
24. Luo D, Cheng SC, Xie H and Xie Y: Effects of Bcl-2 and Bcl-XL protein levels on chemoresistance of hepatoblastoma HepG2 cell line. Biochem Cell Biol 78: 119-126, 2000. (Pubitemid 30353769)
25. Janssen K, Pohlmann S, Jänicke RU, Schulze-Osthoff K and Fischer U: Apaf-1 and caspase-9 deficiency prevents apoptosis in a Bax-controlled pathway and promotes clonogenic survival during paclitaxel treatment. Blood 110: 3662-3672, 2007. (Pubitemid 350159635)
26. Strobel T, Kraeft SK, Chen LB and Cannistra SA: BAX expression is associated with enhanced intracellular accumulation of paclitaxel: a novel role for BAX during chemotherapy-induced cell death. Cancer Res 58: 4776-4781, 1998. (Pubitemid 28503666)
27. Kitazono M, Sumizawa T, Takebayashi Y, Chen ZS, Furukawa T, Nagayama S, Tani A, Takao S, Aikou T and Akiyama S: Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. J Natl Cancer Inst 91: 1647-1653, 1999. (Pubitemid 29479932)
28. Tanaka T, Toujima S, Toyoda S, Takeuchi S and Umesaki N: Establishment and characterization of novel human uterine leiomyosarcoma cell lines. Int J Oncol 35: 125-131, 2010.